FSA Investment Group’s Lam Research LRCX Stock Holding History

FSA Investment Group’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,503	Closed	-$257K	–	47
2025 Q4	$257K	Buy	1,503 +34	+2%	+$5.29K	0.16%	34
2025 Q3	$210K	Buy	+1,469	New	+$156K	0.13%	40

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FSA Investment Group's LRCX Position: Q1 2026 in Review

FSA Investment Group sold out of Lam Research (LRCX) in Q1 2026, closing a stake of 1,503 shares — an estimated $257K sold.

FSA Investment Group first reported a position in LRCX in Q3 2025 and held it in 2 quarters. The position peaked at $257K in Q4 2025. 2,632 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

FSA Investment Group reported no remaining Lam Research position as of Q1 2026 after selling out during the quarter.
FSA Investment Group sold 1,503 Lam Research shares in Q1 2026, an estimated $257K.
FSA Investment Group first reported a position in Lam Research in Q3 2025 and held it in 2 quarters.
FSA Investment Group's Lam Research position peaked at $257K in Q4 2025.
2,632 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on FSA Investment Group's 13F filing for Q1 2026, filed 22 Apr 2026.